{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:58:41Z","timestamp":1780405121238,"version":"3.54.1"},"reference-count":189,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.bpobgyn.2006.04.006","type":"journal-article","created":{"date-parts":[[2006,6,13]],"date-time":"2006-06-13T15:22:33Z","timestamp":1150212153000},"page":"751-778","source":"Crossref","is-referenced-by-count":45,"title":["Polycystic ovarian syndrome \u2013 prognosis and outcomes"],"prefix":"10.1016","volume":"20","author":[{"given":"Roger","family":"Hart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2006.04.006_bib1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bpobgyn.2004.05.001","article-title":"Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome","volume":"18","author":"Hart","year":"2004","journal-title":"Best Practice and Research Clinical Obstetrics and Gynaecology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"ESHRE\/ASRM","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"ESHRE\/ASRM Rotterdam Consensus Meeting Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"ESHRE\/ASRM","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib4","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0015-0282(99)00383-0","article-title":"Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study","volume":"72","author":"Azziz","year":"1999","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0002-9343(73)90184-8","article-title":"Cushing's syndrome: a prospective study of diagnostic methods","volume":"55","author":"Eddy","year":"1973","journal-title":"American Journal of Medicine"},{"issue":"8590","key":"10.1016\/j.bpobgyn.2006.04.006_bib6","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(88)91612-1","article-title":"Polycystic ovaries \u2013 a common finding in normal women","volume":"1","author":"Polson","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2265.1992.tb02296.x","article-title":"How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?","volume":"37","author":"Clayton","year":"1992","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1479-828X.1994.tb01041.x","article-title":"The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women","volume":"34","author":"Farquhar","year":"1994","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1469-0705.1995.06030182.x","article-title":"Sonographic incidence of polycystic ovaries in a gynecological population","volume":"6","author":"Botsis","year":"1995","journal-title":"Ultrasound in Obstetrics and Gynecology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib10","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2265.1999.00886.x","article-title":"Polycystic ovaries and associated clinical and biochemical features in young women","volume":"51","author":"Michelmore","year":"1999","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib11","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/humrep\/17.9.2219","article-title":"What is polycystic ovary syndrome?","volume":"17","author":"Balen","year":"2002","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1479-828X.2005.00334.x","article-title":"Incidence of polycystic ovaries and polycystic ovary syndrome amongst women in Melbourne, Australia","volume":"45","author":"Lowe","year":"2005","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib13","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.fertnstert.2004.04.041","article-title":"Prevalence of polycystic ovaries and polycystic ovary syndrome in lesbian women compared with heterosexual women","volume":"82","author":"Agrawal","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib14","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib15","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jcem-62-5-840","article-title":"Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and\/or hirsutism: adrenal enzyme defects and exaggerated adrenarche","volume":"62","author":"Lucky","year":"1986","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/humrep\/deh079","article-title":"Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at 18 years","volume":"19","author":"van Hooff","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib17","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/humrep\/14.9.2223","article-title":"Endocrine features of polycystic ovary syndrome in a random population sample of 14\u201316 year old adolescents","volume":"14","author":"van Hooff","year":"1999","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1365-2265.2000.01133.x","article-title":"Adrenal hyperandrogenism in adolescent girls with a\u00a0history of low birthweight and precocious pubarche","volume":"53","author":"Ibanez","year":"2000","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1740001","article-title":"Developmental origin of polycystic ovary syndrome \u2013 a hypothesis","volume":"174","author":"Abbott","year":"2002","journal-title":"Journal of Endocrinology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humupd\/dmi013","article-title":"Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?","volume":"11","author":"Abbott","year":"2005","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0739-7240(02)00144-3","article-title":"In utero programming of sexually differentiated gonadotrophin releasing hormone (GnRH) secretion","volume":"23","author":"Robinson","year":"2002","journal-title":"Domestic Animal Endocrinology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib22","first-page":"257","article-title":"Sexual differentiation of the brain of the sheep: effects of prenatal implantation of androgen. Film: general discussion","volume":"62","author":"Short","year":"1978","journal-title":"Ciba Foundation Symposium"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/humupd\/dmi025","article-title":"Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth","volume":"11","author":"Diamanti-Kandarakis","year":"2005","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib24","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/jcem-57-2-356","article-title":"Insulin resistance in nonobese patients with polycystic ovarian disease","volume":"57","author":"Chang","year":"1983","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/humupd\/dmh018","article-title":"Improving reproductive performance in overweight\/obese women with effective weight management","volume":"10","author":"Norman","year":"2004","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib27","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/humrep\/deg367","article-title":"Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet","volume":"18","author":"Crosignani","year":"2003","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib28","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/humrep\/13.6.1502","article-title":"Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment","volume":"13","author":"Clark","year":"1998","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.fertnstert.2004.02.104","article-title":"A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and\/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study","volume":"82","author":"Hoeger","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib30","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1210\/jc.86.12.5925","article-title":"The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome","volume":"86","author":"Nelson","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib31","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1210\/jc.87.3.1337","article-title":"Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome","volume":"87","author":"Teixeira Filho","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib32","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/er.18.6.774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib33","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1210\/jc.2004-1860","article-title":"Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome","volume":"90","author":"Wickenheisser","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"supplement 5","key":"10.1016\/j.bpobgyn.2006.04.006_bib34","first-page":"1315","article-title":"The role of heterozygosity for CYP21 in the polycystic ovary syndrome","volume":"13","author":"Witchel","year":"2000","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib35","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1210\/jc.2003-030197","article-title":"Association of the (TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and\u00a0relation to SHBG serum levels","volume":"88","author":"Xita","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib36","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1210\/jc.87.8.3708","article-title":"A genome-wide linkage scan for steroids and SHBG levels in black and white families: the HERITAGE Family Study","volume":"87","author":"Ukkola","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib37","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1210\/jc.2005-0622","article-title":"Candidate gene region for polycystic ovary syndrome (PCOS) on chromosome 19p13.2","volume":"90","author":"Urbanek","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib38","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/humrep\/17.11.2858","article-title":"Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin","volume":"17","author":"Glueck","year":"2002","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib39","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1530\/eje.0.1500793","article-title":"The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels","volume":"150","author":"Diamanti-Kandarakis","year":"2004","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/humrep\/deh079","article-title":"Predictive values of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at aged 15 years for oligo-amenorrhoea at aged 18 years","volume":"19","author":"van Hooff","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib41","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/humrep\/deh207","article-title":"Polycystic ovary syndrome in adolescence \u2013 a therapeutic conundrum","volume":"19","author":"Homburg","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib42","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1203\/00006450-199512000-00024","article-title":"Longitudinal change of sonographic ovarian aspects and endocrine parameters in irregular cycles of adolescence","volume":"38","author":"Venturoli","year":"1995","journal-title":"Pediatric Research"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1530\/eje.0.1330403","article-title":"Early polycystic ovary-like syndrome in girls with central precocious puberty and exaggerated adrenal response","volume":"133","author":"Lazar","year":"1995","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib44","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1046\/j.1365-2265.2001.01399.x","article-title":"Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect","volume":"55","author":"Ibanez","year":"2001","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpeds.2003.08.015","article-title":"Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome","volume":"144","author":"Ibanez","year":"2004","journal-title":"Journal of Pediatrics"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib46","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0015-0282(02)02993-X","article-title":"Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives","volume":"77","author":"Mastorakos","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib47","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/humrep\/deh588","article-title":"The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients","volume":"20","author":"Cibula","year":"2005","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib48","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2002-020997","article-title":"Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study","volume":"88","author":"Morin-Papunen","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib49","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1210\/jc.85.9.3161","article-title":"Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study","volume":"85","author":"Morin-Papunen","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib50","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/humrep\/17.7.1729","article-title":"Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a\u00a0randomized controlled study","volume":"17","author":"Elter","year":"2002","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/13625180008500375","article-title":"Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone","volume":"5","author":"Huber","year":"2000","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib52","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.contraception.2003.11.003","article-title":"A randomized study on the\u00a0influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles","volume":"69","author":"Gaspard","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib53","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1210\/jc.2004-0047","article-title":"Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of\u00a0early, low-dose flutamide","volume":"89","author":"Ibanez","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jc.2004-1405","article-title":"Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy","volume":"90","author":"Ibanez","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib55","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1367\/A04-130R.1","article-title":"Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life","volume":"5","author":"Trent","year":"2005","journal-title":"Ambulatory Pediatrics"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib56","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bpobgyn.2004.05.007","article-title":"Hirsutism and acne in polycystic ovary syndrome","volume":"18","author":"Archer","year":"2004","journal-title":"Best Practice and Research Clinical Obstetrics and Gynaecology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib57","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1067\/mob.2003.294","article-title":"A randomized controlled trial of second- versus third-generation oral contraceptives in the treatment of acne vulgaris","volume":"188","author":"Rosen","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib58","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/humrep\/16.5.940","article-title":"Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?","volume":"16","author":"Cibula","year":"2001","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib59","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1210\/jc.85.8.2767","article-title":"Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome","volume":"85","author":"Pasquali","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib60","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1365-2125.2002.01575.x","article-title":"Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice","volume":"53","author":"Sturrock","year":"2002","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib61","first-page":"361","article-title":"Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome","volume":"49","author":"Kriplani","year":"2004","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib62","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijgo.2004.08.015","article-title":"Metformin therapy in women with polycystic ovary syndrome","volume":"87","author":"Aruna","year":"2004","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib63","article-title":"Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, d-chiro-inositol) for polycystic ovary syndrome","volume":"3","author":"Lord","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib64","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1210\/jc.2003-031780","article-title":"Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study","volume":"89","author":"Ganie","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib65","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1210\/jc.2003-030424","article-title":"Metformin or antiandrogen in the treatment of hirsutism in\u00a0polycystic ovary syndrome","volume":"88","author":"Harborne","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib66","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1507\/endocrj.52.299","article-title":"Endocrine and metabolic effects of rosiglitazone in non-obese women with polycystic ovary disease","volume":"52","author":"Dereli","year":"2005","journal-title":"Endocrine Journal"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib67","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1210\/jc.86.4.1626","article-title":"Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial","volume":"86","author":"Azziz","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib68","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1056\/NEJM199904293401703","article-title":"Ovulatory and metabolic effects of d-chiro-inositol in the polycystic ovary syndrome","volume":"340","author":"Nestler","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib69","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/humrep\/dei104","article-title":"Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study","volume":"20","author":"Penna","year":"2005","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib70","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/BF03348960","article-title":"Hirsutism and the effectiveness of spironolactone in its management","volume":"16","author":"McMullen","year":"1993","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003139","article-title":"Spironolactone versus placebo or in combination with steroids for hirsutism and\/or acne","volume":"4","author":"Farquhar","year":"2003","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib72","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1530\/eje.0.1500351","article-title":"A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism","volume":"150","author":"Kelestimur","year":"2004","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib73","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/oxfordjournals.humrep.a136243","article-title":"Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients","volume":"10","author":"Balen","year":"1995","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib74","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2265.1989.tb00457.x","article-title":"Polycystic ovary syndrome: a changing perspective","volume":"31","author":"Franks","year":"1989","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib75","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0015-0282(03)01010-0","article-title":"Ultrasound diagnosis of polycystic ovaries in women who have no symptoms of polycystic ovary syndrome is not associated with subfecundity or subfertility","volume":"80","author":"Hassan","year":"2003","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib76","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","article-title":"Obesity and the polycystic ovary syndrome","volume":"26","author":"Gambineri","year":"2002","journal-title":"International Journal of Obesity & Related Metabolic Disorders: Journal of the International Association for the Study of Obesity"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib77","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0015-0282(03)00265-6","article-title":"Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome","volume":"79","author":"Yildirim","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"supplement 1","key":"10.1016\/j.bpobgyn.2006.04.006_bib78","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/humrep\/12.suppl_1.53","article-title":"Insulin regulation of human ovarian androgens","volume":"12","author":"Nestler","year":"1997","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib79","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0303-7207(99)00239-7","article-title":"Follicular dynamics in the polycystic ovary syndrome","volume":"163","author":"Franks","year":"2000","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib80","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00001648-199403000-00016","article-title":"Body mass index and ovulatory infertility","volume":"5","author":"Grodstein","year":"1994","journal-title":"Epidemiology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib81","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0015-0282(16)59466-7","article-title":"Risk factors for spontaneous abortion in menotropin-treated women","volume":"48","author":"Bohrer","year":"1987","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib82","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1093\/humrep\/deh277","article-title":"Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case\u2013control study","volume":"19","author":"Lashen","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib83","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/humrep\/12.3.449","article-title":"Relationship of clomiphene dose and patient weight to successful treatment","volume":"12","author":"Dickey","year":"1997","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib84","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0015-0282(16)55276-5","article-title":"Body weight, body mass index, and age: predictors of menotropin dose and cycle outcome in polycystic ovarian syndrome?","volume":"58","author":"McClure","year":"1992","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib85","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1210\/jc.82.2.556","article-title":"17 Alpha-hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss","volume":"82","author":"Jakubowicz","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.1993.tb01744.x","article-title":"The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women","volume":"39","author":"Pasquali","year":"1993","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib87","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/sj.ijo.0802258","article-title":"Weight management using a meal replacement strategy: meta and pooling analysis from six studies","volume":"27","author":"Heymsfield","year":"2003","journal-title":"International Journal of Obesity and Related Metabolic Disorders"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib88","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/humrep\/dei128","article-title":"Ovulation induction: a mini review","volume":"20","author":"Messinis","year":"2005","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib89","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0015-0282(01)01749-6","article-title":"A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction","volume":"75","author":"Boostanfar","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"3 supplement 1","key":"10.1016\/j.bpobgyn.2006.04.006_bib90","first-page":"S234","article-title":"Randomised study of induction of ovulation by two different molecules with antiestrogenic effects, in patients with chronic anovulation disorders","volume":"72","author":"Vegetti","year":"1999","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib91","article-title":"Oral anti-oestrogens and medical adjuncts for subfertility associated with anovulation","volume":"1","author":"Beck","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib92","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0015-0282(16)47896-9","article-title":"A randomized study of dexamethasone in ovulation induction with clomiphene citrate","volume":"41","author":"Daly","year":"1984","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib93","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0015-0282(02)04206-1","article-title":"Use of dexamethasone and clomiphene citrate in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome and normal dehydroepiandrosterone sulfate levels: a prospective, double-blind, placebo-controlled trial","volume":"78","author":"Parsanezhad","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib94","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1067\/mob.2003.459","article-title":"A randomized clinical trial of treatment of clomiphene citrate-resistant anovulation with the use of oral contraceptive pill suppression and repeat clomiphene citrate treatment","volume":"188","author":"Branigan","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib95","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00404-002-0437-x","article-title":"A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level","volume":"269","author":"Parsanezhad","year":"2004","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib96","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.fertnstert.2004.07.952","article-title":"Single-dose administration of an aromatase inhibitor for ovarian stimulation","volume":"83","author":"Mitwally","year":"2005","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib97","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/humrep\/deg311","article-title":"Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility","volume":"18","author":"Mitwally","year":"2003","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib98","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijgo.2003.11.010","article-title":"Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome","volume":"85","author":"Al-Omari","year":"2004","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib99","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0015-0282(00)01705-2","article-title":"Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate","volume":"75","author":"Mitwally","year":"2001","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib100","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ajog.2004.08.013","article-title":"Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation","volume":"192","author":"Mitwally","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib101","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1023\/A:1013165006406","article-title":"Improved responsiveness of PCOS patients to clomiphene after CYP17a inhibitor","volume":"18","author":"Ali Hassan","year":"2001","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib102","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1093\/humrep\/deh440","article-title":"Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome","volume":"19","author":"Kashyap","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib103","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity","volume":"82","author":"Baillargeon","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib104","doi-asserted-by":"crossref","first-page":"16767","DOI":"10.1074\/jbc.M100040200","article-title":"Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3beta -hydroxysteroid dehydrogenase","volume":"276","author":"Arlt","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-9343(02)01529-2","article-title":"Troglitazone-induced liver failure: a case study","volume":"114","author":"Graham","year":"2003","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib106","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000410","article-title":"Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome","volume":"4","author":"Nugent","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib107","series-title":"Low-dose Gonadotrophin Treatment in Polycystic Ovary Syndrome: The Step-up Protocol","author":"Franks","year":"2002"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib108","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/humupd\/5.5.493","article-title":"Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements","volume":"5","author":"Homburg","year":"1999","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib109","series-title":"The Step-Down Protocol","author":"Macklon","year":"2002"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib110","series-title":"National Institute of Clinical Excellence Report on Fertility Assessment and Treatment for People with Fertility Problems","author":"NICE","year":"2004"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib111","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/humrep\/deg234","article-title":"An open, randomized single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin alpha administered by a conventional syringe in women undergoing ovarian stimulation for IVF\/ICSI","volume":"18","author":"Platteau","year":"2003","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib112","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0015-0282(99)00208-3","article-title":"Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome","volume":"72","author":"De Leo","year":"1999","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib113","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/humrep\/17.2.289","article-title":"Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial","volume":"17","author":"Yarali","year":"2002","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib114","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001122.pub2","article-title":"Laparoscopic \u201cdrilling\u201d by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome","volume":"3","author":"Farquhar","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0015-0282(16)47534-5","article-title":"Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope","volume":"41","author":"Gjonnaess","year":"1984","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib116","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0015-0282(16)57051-4","article-title":"A prospective study comparing unilateral and bilateral laparoscopic ovarian diathermy in women with the polycystic ovary syndrome","volume":"62","author":"Balen","year":"1994","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib117","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/bmj.328.7433.192","article-title":"Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial","volume":"328","author":"Bayram","year":"2004","journal-title":"British Medical Journal"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib118","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0015-0282(02)03225-9","article-title":"A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate-resistant polycystic ovary syndrome","volume":"78","author":"Farquhar","year":"2002","journal-title":"Fertility and Sterility"},{"issue":"supplement","key":"10.1016\/j.bpobgyn.2006.04.006_bib119","first-page":"472","article-title":"Medicaments or surgical therapy of PCOS","volume":"70","author":"Lazovic","year":"1998","journal-title":"Fertility and Sterility"},{"issue":"supplement","key":"10.1016\/j.bpobgyn.2006.04.006_bib120","first-page":"120","article-title":"Laparoscopic ovarian drilling versus low-dose pure FSH in anovulatory clomiphene-resistant patients with polycystic ovarian syndrome: randomized prospective study","volume":"13","author":"Vegetti","year":"1998","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib121","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/humrep\/17.4.1046","article-title":"Laparoscopic ovarian diathermy in women with polycystic ovarian syndrome: a retrospective study on the influence of the amount of energy used on the outcome","volume":"17","author":"Amer","year":"2002","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib122","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/humrep\/deh343","article-title":"Ovulation induction using laparoscopic ovarian drilling in women with polycystic ovarian syndrome: predictors of success","volume":"19","author":"Amer","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib123","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1210\/jc.2004-0689","article-title":"Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial","volume":"89","author":"Palomba","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib124","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1210\/jc.79.4.1215","article-title":"Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles","volume":"79","author":"Filicori","year":"1994","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib125","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0015-0282(16)55794-X","article-title":"Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome","volume":"59","author":"Homburg","year":"1993","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib126","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/oxfordjournals.humrep.a138174","article-title":"Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin","volume":"8","author":"Balen","year":"1993","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib127","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1136\/bmj.312.7045.1508","article-title":"Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial","volume":"312","author":"Clifford","year":"1996","journal-title":"British Medical Journal"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib128","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0015-0282(02)04696-4","article-title":"Concurrent ganirelix and follitropin beta therapy is an effective and safe regimen for ovulation induction in women with polycystic ovary syndrome","volume":"79","author":"Elkind-Hirsch","year":"2003","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib129","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/oxfordjournals.humrep.a137702","article-title":"In-vitro fertilization and the ovarian hyperstimulation syndrome","volume":"7","author":"MacDougall","year":"1992","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib130","first-page":"611","article-title":"Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review","volume":"84","author":"Tummon","year":"2005","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib131","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0029-7844(02)02193-2","article-title":"A comparison of in vitro maturation and in vitro fertilization for women with polycystic ovaries","volume":"100","author":"Child","year":"2002","journal-title":"Obstetrics and Gynecology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib132","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/humupd\/dmi036","article-title":"A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome","volume":"12","author":"Heijnen","year":"2006","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib133","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejogrb.2004.12.002","article-title":"Comparison of in vitro fertilization outcome in women with and without sonographic evidence of polycystic ovarian morphology","volume":"121","author":"Esmailzadeh","year":"2005","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib134","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.fertnstert.2005.04.028","article-title":"Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries","volume":"84","author":"Esinler","year":"2005","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib135","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bpobgyn.2004.05.006","article-title":"Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome","volume":"18","author":"Homburg","year":"2004","journal-title":"Best Practice and Research Clinical Obstetrics and Gynaecology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib136","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/humrep\/12.7.1443","article-title":"The use of laparoscopic ovarian electrocautery in preventing cancellation of in-vitro fertilization treatment cycles due to risk of ovarian hyperstimulation syndrome in women with polycystic ovaries","volume":"12","author":"Rimington","year":"1997","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib137","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/humrep\/16.1.91","article-title":"Does laparoscopic ovarian diathermy affect the outcome of IVF-embryo transfer in women with polycystic ovarian syndrome? A retrospective comparative study","volume":"16","author":"Tozer","year":"2001","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib138","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3109\/00016349709024583","article-title":"In vitro fertilization following laparoscopic ovarian diathermy in patients with polycystic ovarian syndrome","volume":"76","author":"Colacurci","year":"1997","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib139","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(00)01766-0","article-title":"Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors","volume":"75","author":"Stadtmauer","year":"2001","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib140","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/713603249","article-title":"The effect of metformin on ovarian stimulation and in vitro fertilization in insulin-resistant women with polycystic ovary syndrome: an open-label randomized cross-over trial","volume":"17","author":"Fedorcsak","year":"2003","journal-title":"Gynecological Endocrinology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib141","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/humrep\/deh248","article-title":"Metformin treatment before IVF\/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study","volume":"19","author":"Kjotrod","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib142","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.fertnstert.2005.03.043","article-title":"Metformin treatment in patients with polycystic ovary syndrome undergoing in vitro fertilization: a prospective randomized trial","volume":"84","author":"Onalan","year":"2005","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib143","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00001703-200406000-00007","article-title":"Should we continue or stop insulin sensitizing drugs during pregnancy?","volume":"16","author":"Norman","year":"2004","journal-title":"Current Opinion in Obstetrics and Gynecology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib144","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1742-7843.2005.pto_96602.x","article-title":"Is metformin therapy for polycystic ovary syndrome safe during pregnancy?","volume":"96","author":"Brock","year":"2005","journal-title":"Basic and Clinical Pharmacology and Toxicology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib145","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/bmj.326.7392.762\/a","article-title":"Contraindications to use of metformin. Metformin may be useful in gestational diabetes","volume":"326","author":"Hague","year":"2003","journal-title":"British Medical Journal"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib146","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00024677-200403030-00001","article-title":"Is there a role for oral antihyperglycemics in gestational diabetes and type 2 diabetes during pregnancy?","volume":"3","author":"Homko","year":"2004","journal-title":"Treatments in Endocrinology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib147","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/oxfordjournals.humrep.a138703","article-title":"An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases","volume":"9","author":"Clifford","year":"1994","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib148","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1479-828X.1997.tb02447.x","article-title":"Recurrent miscarriage: screening for polycystic ovaries and subsequent pregnancy outcome","volume":"37","author":"Liddell","year":"1997","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib149","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1471-0528.1993.tb12978.x","article-title":"Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: prospective study in 50 women","volume":"100","author":"Tulppala","year":"1993","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib150","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/humrep\/15.3.612","article-title":"Polycystic ovaries and recurrent miscarriage\u2013-a reappraisal","volume":"15","author":"Rai","year":"2000","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib151","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/jc.87.2.524","article-title":"Effects of metformin on early pregnancy loss in the polycystic ovary syndrome","volume":"87","author":"Jakubowicz","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib152","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0015-0282(00)01666-6","article-title":"Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study","volume":"75","author":"Glueck","year":"2001","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib153","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1053\/meta.2000.6749","article-title":"The 4G\/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications","volume":"49","author":"Glueck","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib154","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0026-0495(99)90250-0","article-title":"Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome","volume":"48","author":"Glueck","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib156","first-page":"601","article-title":"Plasma homocysteine levels in polycystic ovary syndrome and congenital adrenal hyperplasia","volume":"51","author":"Bayraktar","year":"2004","journal-title":"Endocrinology Journal"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib157","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0015-0282(01)03202-2","article-title":"Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome","volume":"77","author":"Glueck","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib158","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/humrep\/deh263","article-title":"Height, weight, and motor-social development during the\u00a0first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy","volume":"19","author":"Glueck","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib159","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/humrep\/deh347","article-title":"Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study","volume":"19","author":"Vanky","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib160","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/humupd\/dmi015","article-title":"Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome","volume":"11","author":"Checa","year":"2005","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib161","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1016\/S0002-9343(99)80057-6","article-title":"Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an\u00a0increased risk of non-insulin-dependent diabetes mellitus","volume":"98","author":"Dunaif","year":"1995","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib162","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(16)54892-4","article-title":"Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones","volume":"57","author":"Dahlgren","year":"1992","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib163","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jc.84.1.165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib164","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib165","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/humrep\/16.9.1995","article-title":"Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non insulin dependent diabetes mellitus in polycystic ovarian syndrome","volume":"16","author":"Norman","year":"2001","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib166","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2003-030334","article-title":"Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome","volume":"88","author":"Christian","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib167","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","author":"Legro","year":"2001","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib168","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7326\/0003-4819-126-1-199701010-00005","article-title":"Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization","volume":"126","author":"Birdsall","year":"1997","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib169","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.atherosclerosis.2004.04.007","article-title":"Intima\u2013media thickness of elastic and muscular arteries of young women with polycystic ovaries","volume":"175","author":"Lakhani","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/01.CIR.0000020681.19400.8A","article-title":"Impaired carotid viscoelastic properties in women with polycystic ovaries","volume":"106","author":"Lakhani","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib171","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women","volume":"20","author":"Talbott","year":"2000","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib172","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0002-9378(96)70665-8","article-title":"Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case\u2013control study","volume":"174","author":"Guzick","year":"1996","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib173","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1210\/jc.2005-0011","article-title":"Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease","volume":"90","author":"Meyer","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib174","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1093\/humrep\/dei100","article-title":"Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome","volume":"20","author":"Vural","year":"2005","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib175","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0895-4356(98)00035-3","article-title":"Mortality of women with polycystic ovary syndrome at long-term follow-up","volume":"51","author":"Pierpoint","year":"1998","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib176","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/00016349209006227","article-title":"Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women","volume":"71","author":"Dahlgren","year":"1992","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib177","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/S0140-6736(03)13409-5","article-title":"Polycystic ovary syndrome and endometrial carcinoma","volume":"361","author":"Hardiman","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib178","first-page":"89","article-title":"A case\u2013control study of uterine endometrial cancer of pre- and post-menopausal women","volume":"7","author":"Niwa","year":"2000","journal-title":"Oncology Reports"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib179","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/jnci\/88.16.1127","article-title":"Case\u2013control study of endogenous steroid hormones and endometrial cancer","volume":"88","author":"Potischman","year":"1996","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib180","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<494::AID-CNCR10>3.0.CO;2-Z","article-title":"Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa","volume":"79","author":"Anderson","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib181","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1742-1241.2005.00417.x","article-title":"The prevalence of benign breast disease in women with polycystic ovary syndrome: a review of a 12-year follow-up","volume":"59","author":"Soran","year":"2005","journal-title":"International Journal of Clinical Practice"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib182","first-page":"403","article-title":"Chronic anovulation syndrome and associated neoplasia","volume":"61","author":"Coulam","year":"1983","journal-title":"Obstetrics and Gynecology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib183","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/oxfordjournals.aje.a116156","article-title":"Polycystic ovaries and the risk of breast cancer","volume":"134","author":"Gammon","year":"1991","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib184","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/humupd\/8.3.231","article-title":"Long-term health consequences of PCOS","volume":"8","author":"Wild","year":"2002","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib185","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2005-0628","article-title":"Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span","volume":"90","author":"Azziz","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib186","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.2337\/diabetes.54.4.1150","article-title":"Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program","volume":"54","author":"Knowler","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib187","first-page":"126","article-title":"American Association of Clinical Endocrinologists Position Statement on metabolic and cardiovascular consequences of polycystic ovary syndrome","volume":"11","author":"American Association of Clinical Endocrinologists","year":"2005","journal-title":"Endocrine Practice"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib188","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1210\/jc.2003-030562","article-title":"Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome","volume":"88","author":"Elsenbruch","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib189","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/humrep\/deh432","article-title":"Infertility caused by PCOS \u2013 health-related quality of life among Austrian and Moslem immigrant women in Austria","volume":"19","author":"Schmid","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1016\/j.bpobgyn.2006.04.006_bib190","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jclinepi.2003.10.018","article-title":"Health\u2013related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated","volume":"57","author":"Guyatt","year":"2004","journal-title":"Journal of Clinical Epidemiology"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693406000629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693406000629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T09:58:03Z","timestamp":1555667883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693406000629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":189,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S1521693406000629"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2006.04.006","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}